Deep Medicine (DMAQ) Terminates Chijet Motor Company Deal
by Marlena Haddad on 2022-09-30 at 9:06am

Deep Medicine (NASDAQ:DMAQ) announced this morning that it has terminated its $2.5 billion combination with Chinese carmaker Chijet.

Deep Medicine’s move comes after it made two amendments to the deal to extend the due diligence period. The first amendment was made on September 6, to extend Chijet’s due diligence period until September 20, in an effort to review the company’s operations and complete its own valuation of the Chinese carmaker. On September 16, the parties entered into the second amendment to extend the diligence expiration date until September 30. However, on September 26, Deep Medicine sent Chijet a termination notice.

The deal included a minimum cash condition of at least $10 million. Deep Medicine brought about $127.8 million from its current trust into the deal and did not supplement this with a PIPE.

Deep Medicine and Chijet mark the 45th deal to be terminated this year. The SPAC will not be obligated to pay any penalties pursuant to the terms of the business combination agreement as a result of the termination.

Deep Medicine initially announced its definitive agreement to combine with Chijet just a few months ago on July 13, 2022. Chijit currently sells a line of gasoline-fueled SUVs and trucks in China and Southeast Asia and is working to build a production facility for a new line of EVs.

 

Recent Posts
by Kristi Marvin on 2024-07-13 at 11:44am

Terms Tracker for the Week Ending July 12, 2024 Welcome to our weekly column where we discuss the findings from our IPO terms tracker based on the previous week’s pricings. The rush is on to price the SPAC IPOs with anchor investors while they still can and Cantor managed to push out two of them...

by Nicholas Alan Clayton on 2024-07-12 at 8:17am

At the SPAC of Dawn With all eyes on the fireworks both literal and figurative in Western politics this month, July has hosted a relative drought of new business combinations with just one so far announced. But, there are flashes on the horizon as three SPACs signed letters of intent to combine with targets in...

by Nicholas Alan Clayton on 2024-07-11 at 4:59pm

Launch One Acquisition Corp. announced the pricing of its $200 million IPO and its units are expected to begin trading on the Nasdaq under the symbol “LPAAU”, Friday, July 12, 2024. The new SPAC aims to combine with an established company of scale in healthcare and healthcare-related industries and, in particular, life sciences, globally. Launch...

by Nicholas Alan Clayton on 2024-07-11 at 8:24am

At the SPAC of Dawn As the market awaits the reading for the US’ CPI numbers for June at 8:30 am ET, SPAC teams are increasingly looking outside of the US for filing their initial corporate documents. So far, none of the 34 SPACs that have filed for IPOs in 2024 have been domiciled in...

by Nicholas Alan Clayton on 2024-07-10 at 8:11am

At the SPAC of Dawn Wednesday is set to be potentially the busiest day of the week for SPACs with three extension votes and a completion vote for investors to get through. The day also holds the possibility of being the month’s first debut of multiple SPACs at once as SIM I (NASDAQ:SIMAU) priced overnight...

logo

Copyright © 2023 SPACInsider, Inc. All Rights Reserved